850102 | 16:0 Lyso PI
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt)

Info
16:0 Lyso PI
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt)
Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.
Data
No
No
C25H52NO12P
C 50.92%, H 8.89%, N 2.38%, O 32.56%, P 5.25%
>99% LPI; may contain up to 10% of the 2-LPI isomer
1 Years
-20°C
CAS Number
141553-69-7
CAS Registry Number is a Registered Trademark of the American Chemical Society
CAS Registry Number is a Registered Trademark of the American Chemical Society
589.654
589.323
1-hexadecanoyl-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt)
PI(16:0/0:0)
110717
PI(16:0/0:0)
110717
References
Helsley RN, Varadharajan V, Brown AL, Gromovsky AD, Schugar RC, Ramachandiran I, Fung K, Kabbany MN, Banerjee R, Neumann CK, Finney C, Pathak P, Orabi D, Osborn LJ, Massey W, Zhang R, Kadam A, Sansbury BE, Pan C, Sacks J, Lee RG, Crooke RM, Graham MJ, Lemieux ME, Gogonea V, Kirwan JP, Allende DS, Civelek M, Fox PL, Rudel LL, Lusis AJ, Spite M, Brown JM. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. Elife. 2019 Oct 17;8. pii: e49882. doi: 10.7554/eLife.49882.
PubMed ID: 31621579
Certificates of Analysis
- Certificate of Analysis (Lot No. 850102P-100UG-C-010 and 5588PDC010)
- Certificate of Analysis (Lot No. 850102P-500UG-B-010 and 5588PFB010)
- Certificate of Analysis (Lot No. 850102P-100UG-D-010 and 5588PDD010)
- Certificate of Analysis (Lot No. 850102P-100UG-A-011 and 5588PDA011)